title: Growth retardation in the newborn of ulcerative colitis patients can be the consequence of drug therapy.
authors.forename: T
authors.initials: T
authors.lastname: Molnár
authors.forename: K
authors.initials: K
authors.lastname: Farkas
authors.forename: F
authors.initials: F
authors.lastname: Nagy
authors.forename: Z
authors.initials: Z
authors.lastname: Szepes
authors.forename: T
authors.initials: T
authors.lastname: Wittmann
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000636:Aminosalicylic Acids / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*; D012307:Risk Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D001379:Azathioprine